<noframes id="lx9dz"><form id="lx9dz"></form>
    <address id="lx9dz"></address>

          <em id="lx9dz"><span id="lx9dz"></span></em>
          <span id="lx9dz"></span>
          <noframes id="lx9dz"><form id="lx9dz"></form>
          <address id="lx9dz"></address>

          <noframes id="lx9dz">

            更新于 4月21日

            結構計算科學家

            2.5-3.5萬·13薪
            • 成都雙流區
            • 3-5年
            • 博士
            • 全職
            • 招1人

            職位描述

            定量構效關系PythonUnixlinux藥物輔助設計
            The Huiyu Biopharma Research group at Chengdu, China is growing in key areas including computational biology. Our research focuses on discovering innovative biologics for unmet patient’s needs, by applying advanced antibody discovery and protein engineering technologies. In the computational biology group we apply comprehensive computational technologies to accelerate biotechnology research and development. We aim to build an integrated intelligent system to push the boundary of innovation to create better medicines. We work closely with colleagues from discovery and protein engineering, formulation and development, as well as oncology and immunology. Our team is looking for a motivated scientist with computational structural biology expertise to join us and to make a difference for patients. Responsibilities: As an outstanding computational biologist, this scientist will make an impact on our R&D portfolio, with the unique opportunity to help drive discovery projects from inception to early development. Specifically, you will ? Develop and establish structure-based computational methods and technical framework to advance discovery and development of wide array of therapeutic modalities including antibody, conjugates, fusion proteins and beyond ? Identify and execute independent structural and computational strategies to accelerate project delivery, as well as to facilitate core platforms ? Provide structural biology insights to drive protein design for drug-like properties, immunogen or for preferred functionalities ? Effectively collaborate with cross-functional project teams; identify key needs and apply computational approaches accordingly ? Maintain strong engagement with external professionals and outside vendors ? Mentor and develop junior scientists Basic Requirements: ? Ph.D. in computational & structural biology, structural bioinformatics, or related field; postdoc and/or industry experience preferred ? Computer programming skills in R or Python in Unix or Linux Preferences: ? 3 or more years of relevant experience beyond education/postdoctoral training in a pharmaceutical, biotech, or research organization ? Deep domain expertise on protein structure prediction, computational analysis on protein properties, protein-protein interaction, and/or protein-ligand docking and screening ? Familiar with Alphafold software, database and API ? Proficient with powerful computational tools, such as Discovery Studio/Biovia, MOE or Rosetta ? Experience with molecular dynamics simulation, coarse-grained simulation ? Protein chemistry or protein engineering experience is a plus ? Creative problem solver and be able to influence team in positive direction ? Strong teammate and willingness to work effectively in a collaborative, fast-paced, multi-tasking environment Additional Preferences: Experience of or interested in learning ? Antibody sequence analysis and/or Ig-Seq data analysis ? Machine learning, deep learning or AI related algorithms

            工作地點

            成都雙流區四川匯宇海玥醫藥科技有限公司

            職位發布者

            牟女士/HRBP

            今日活躍
            立即溝通
            公司Logo四川匯宇海玥醫藥科技有限公司
            四川匯宇制藥股份有限公司生產基地位于四川省內江經濟技術開發區內,占地面積10萬平方米,項目總投資10億元人民幣,致力于高端抗腫瘤藥物的研發,生產和銷售。公司在四川成都雙流區“天府國際生物城”設立全球創新藥研發中心,將打造抗體抗癌創新藥物研發總部及產業化基地,建設包括從事靶向抗腫瘤小分子化學藥和大分子生物藥研發、中試及產業化的研發中心,占地面積60畝,規劃建筑面積88000平方米,可容納1500名研發人員,計劃在2022年建成運行。公司以科技創新為導向的發展理念,不斷完善小分子化學藥物和單克隆抗體生物藥物兩個技術平臺,開發抗腫瘤領域的創新藥物,公司一期項目可年產3000萬瓶抗癌針劑,實現年產值25億元人民幣。公司的抗癌針劑于2014年通過英國GMP認證,并于同年順利通過中國GMP認證。2015年7月公司獲得歐盟藥品放行資質,公司生產的抗癌針劑已經在伊麗莎白女王醫院、皇家倫敦醫院和劍橋大學附屬醫院等1200多家歐盟醫院作為一線抗癌藥物大規模使用。公司在美國、英國、法國、澳大利亞、加拿大、中國香港等全球80多個國家和地區建立了銷售渠道并啟動了當地的藥品注冊工作,已逐步建立并完善遍布全球的銷售網絡。同時以致力于改善人類健康為崇高宗旨,以‘關愛生命,追求卓越,簡單誠信’為價值導向,力爭把公司打造成一家受人尊敬的國際化制藥企業。
            公司主頁
            天天综合色天天综合网